Larvol Delta - Secukinumab-Delays-Time-to-Relapse-in-Patients-with-Polymyalgia-Rheumatica-After-Treatment-Discontinuation-Results-from-the-TreatmentFree-Followup-Period-in-REPLENISH

Cosentyx (secukinumab) - Novartis

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1896607&mode=presInfo

Robert F. Spiera, MD

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next